foxo4-dri peptide senolytic animal model 2023

foxo4-dri peptide senolytic animal model 2023 The disordered p53 transactivation domain is the target of FOXO4 and the compound Peptide inhibitors targeting FOXO4-p53 interactions

Name: foxo4-dri peptide senolytic animal model 2023 The disordered p53 transactivation domain is the target of FOXO4 and the compound Peptide inhibitors targeting FOXO4-p53 interactions
Brand: metron-ms.com
SKU: 7807008143
Price: 25.04 USD
Availability: InStock
Rating: 4.5427 (14 reviews)

Peptide inhibitors targeting FOXO4 p53 interactions and inducing senescent cancer cell specific apoptosis bioRxiv FOXO4 an overview ScienceDirect Topics FOXO4 DRI 5mg 99 EU COA, fast EU shipping PeptidLabs FOXO4 DRI: Human Trial Status, Cancer Research & Senolytic Data The FOXO4 peptide in a DRI conformation (D amino acids in a retro reversed sequence), henceforth named FOXO4 DRI, competes with FOXO4 for p53 binding in a dose dependent manner and doing so with higher affinity.

SKU: 7807008143 · From metron-ms.com

4.5

USD25.04 USD74.04

Pay in 4 interest-free payments of $6.26 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 1 - Aug 6

Description

doi: 10.1189/jlb.0607397 127 BoydJHKanBRobertsHWangYWalleyKR

Monitoring adverse event reports and maintaining communication with healthcare providers important for identifying problems

R2.15 We suggest that transitional care should be provided by a multidisciplinary team which should ideally include both pediatric and adult professionals with experience in DSD management